ZYLM (Central Asia Lumeichun Biotechnology) Retained Earnings: $-3.74 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Central Asia Lumeichun Biotechnology Retained Earnings?

Central Asia Lumeichun Biotechnology ZYLM Retained Earnings is $-3.74 Mil as of Jun. 2026.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Central Asia Lumeichun Biotechnology's retained earnings for the quarter that ended in Jun. 2026 was $-3.74 Mil.

Central Asia Lumeichun Biotechnology's quarterly retained earnings increased from Dec. 2025 ($-3.71 Mil) to Mar. 2026 ($-3.69 Mil) but then declined from Mar. 2026 ($-3.69 Mil) to Jun. 2026 ($-3.74 Mil).

Central Asia Lumeichun Biotechnology's annual retained earnings declined from Aug. 2023 ($-5.68 Mil) to Dec. 2024 ($-6.41 Mil) but then increased from Dec. 2024 ($-6.41 Mil) to Dec. 2025 ($-3.71 Mil).


Central Asia Lumeichun Biotechnology  (OTCPK:ZYLM) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Central Asia Lumeichun Biotechnology Retained Earnings Historical Data

* Premium members only.

The historical data trend for Central Asia Lumeichun Biotechnology's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Asia Lumeichun Biotechnology Retained Earnings Chart

Central Asia Lumeichun Biotechnology Annual Data
Trend Mar07 Mar08 Mar09 Mar10 Mar11 Mar14 Mar15 Aug23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.81 -5.68 -6.41 -3.71

Central Asia Lumeichun Biotechnology Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun13 Jun15 Sep15 Dec15 Nov22 Feb23 May23 Aug23 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.61 -6.73 -3.71 -3.69 -3.74

Central Asia Lumeichun Biotechnology Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-3.74 Mil mean?
Central Asia Lumeichun Biotechnology (ZYLM) has a Retained Earnings of $-3.74 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Central Asia Lumeichun Biotechnology and its competitors.
Is Central Asia Lumeichun Biotechnology's Retained Earnings too high?
Central Asia Lumeichun Biotechnology's current Retained Earnings is $-3.74 Mil.
How does Central Asia Lumeichun Biotechnology's Retained Earnings compare to RHE and DVCR?
Central Asia Lumeichun Biotechnology's Retained Earnings of $-3.74 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Consumer Packaged Goods company?
A good Retained Earnings depends on the Consumer Packaged Goods industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Central Asia Lumeichun Biotechnology and its competitors. Central Asia Lumeichun Biotechnology's current Retained Earnings is $-3.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Asia Lumeichun Biotechnology stock overvalued right now?
Central Asia Lumeichun Biotechnology (ZYLM) has a current Retained Earnings of $-3.74 Mil. The current Retained Earnings is $-3.74 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Central Asia Lumeichun Biotechnology (ZYLM), the current Retained Earnings is $-3.74 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Central Asia Lumeichun Biotechnology Business Description

Address Longguan Avenue, Room 1401, Yunhua Building, Longhua District, Shenzhen, CHN
Central Asia Lumeichun Biotechnology Inc is an ecological agriculture company. It operates a sika deer breeding base in southern China.